EUVIMEDEUVIMED entdecken
Open Access

Effect of quercetin on doxorubicin cytotoxicity in sensitive and resistant human MCF7 breast cancer cell lines

Bayan Almohammad Aljabr, Malek Zihlif, Rana Abu-Dahab, Hiba Zalloum

Biomedical Reports · 05.02.2024 · 20 (4)

DOI: 10.3892/br.2024.1745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Reports, online erschienen am 05.02.2024. Verfasst von Bayan Almohammad Aljabr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, The University of Jordan, Amman 11942, Jordan. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance is the major cause of cancer recurrence, relapse and eventual death. Doxorubicin resistance is one such challenge in breast cancer. The use of quercetin, an antioxidant, in combination with doxorubicin has been investigated for offering protection to normal cells from the toxic side effects of doxorubicin in addition to modulation of its resistance. The present study aimed to investigate the effects of quercetin in prevention of a doxorubicin-chemoresistant phenotype in both doxorubicin-sensitive and -resistant human MCF-7 breast cancer cell lines. A doxorubicin-resistant MCF-7 cell line was established. The development of resistant cells was closely monitored for changes in morphological features. Sensitivity to doxorubicin and the doxorubicin/quercetin combination was assessed using the tetrazolium assay. To determine the mechanism by which quercetin sensitizes the doxorubicin MCF-7-resistant cell line to doxorubicin, gene expression alterations in breast cancer-related genes were examined using the reverse transcription-quantitative PCR (RT-qPCR) array technology. Resistant MCF cells were successfully developed and the inhibitory concentration (IC50) value of doxorubicin increased from 0.133 to 4 µM (wild-type to resistant). The effects of the quercetin/doxorubicin combination exhibited different effects on wild-type vs. resistant cells. The IC50 of doxorubicin was reduced in wild cells, whereas resistant cells showed an increase in cell viability at lower concentrations and a potentiation of the effects of doxorubicin only at higher concentrations. Annexin V/propidium iodide staining demonstrated that quercetin drives cells into late apoptosis and necrosis, but in resistant cells, necrosis predominates. RT-qPCR results revealed that quercetin led to a reversal in doxorubicin effects via up- and downregulation of important genes such as SNAI2, PLAU and CSF1 genes. Downregulation of cell migration genes, SNAI2 (-31.23-fold) and plasminogen activator, urokinase (PLAU; -30.62-fold), and the apoptotic pathway gene, colony stimulating factor 1 (CSF1; -17.25-fold) were the most important querticin-associated events. Other gene alterations were also observed involving cell cycle arrest and DNA repair pathways. The results of the present study indicated that quercetin could lead to a reversal of doxorubicin resistance in breast cancer cells via downregulation of the expression of important genes, such as SNAI2, PLAU and CSF1. Such findings may represent a potential strategy for reversing breast cancer cell-related chemoresistance.

Schlagwörter

Stichwörter der Autor:innen

MCF7breast cancercancer resistancechemoresistancedoxorubicinquercetin

Autor:innen und Institutionen

  • Department of Pharmacology, School of Medicine, The University of Jordan, Amman 11942, Jordan.
  • Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.
  • Hamdi Mango Research Center for Scientific Research, The University of Jordan, Amman 11942, Jordan.

Zitieren

APA

Almohammad Aljabr, B., Zihlif, M., Abu-Dahab, R., & Zalloum, H. (2024). Effect of quercetin on doxorubicin cytotoxicity in sensitive and resistant human MCF7 breast cancer cell lines. Biomedical Reports, 20(4). https://doi.org/10.3892/br.2024.1745

Vancouver

Almohammad Aljabr B, Zihlif M, Abu-Dahab R, Zalloum H. Effect of quercetin on doxorubicin cytotoxicity in sensitive and resistant human MCF7 breast cancer cell lines. Biomedical Reports. 2024;20(4). doi:10.3892/br.2024.1745

BibTeX
@article{AlmohammadAljabr2024,
  author = {Almohammad Aljabr, Bayan and Zihlif, Malek and Abu-Dahab, Rana and Zalloum, Hiba},
  title = {Effect of quercetin on doxorubicin cytotoxicity in sensitive and resistant human MCF7 breast cancer cell lines},
  journal = {Biomedical Reports},
  year = {2024},
  volume = {20},
  number = {4},
  doi = {10.3892/br.2024.1745}
}
Kostenlos starten →